Clinical review for general practice

ISSN (Print) 2713-2552
ISSN (Online) 2782-5671
  • Home
  • about
  • archives
  • contacts
left
FULLSCREEN > Archive > 2024 > Vol 5, №2 (2024) > Clinical case of progressive pulmonary mycobacteriosis with potential genetic predisposition in a patient with mild bronchial asthma

Clinical case of progressive pulmonary mycobacteriosis with potential genetic predisposition in a patient with mild bronchial asthma

Natalia N. Makariantz , Maria A. Karnaushkina , Svetlana A. Salamaikina , Konstantin O. Mironov , Sergey L. Babak , Anastasia D. Strutynskaya

For citation:


  • Abstract
  • About the Author
  • References

Abstract

Mycobacteriosis is an infectious disease caused by opportunistic non-tuberculous microbacteria in patients with chronic respiratory pathology and decreased immunological reactivity. The number of patients with this pathology is increasing not only in Russia, but throughout the world. Scientists' attention was drawn to the fact that the isolation of non-tuberculous mycobacteria from patient’s sputum samples does not correlate with the incidence of non-tuberculous mycobacteriosis and the need for its treatment. This may be due to the presence of gene polymorphisms that affect the structure and functional characteristics of innate immune factors. The article presents a rare clinical case of non-tuberculous mycobacteriosis caused by Mycobacterium avium in a 50-year-old woman without severe concomitant diseases and secondary immunodeficiency. The genetic study revealed polymorphic gene alleles, which may predispose this patient for the infection and severe course of this disease. 
Keywords: non-tuberculous mycobacteriosis, pulmonary disease, immunodeficiency, gene polymorphisms, innate immunity

About the Author

Natalia N. Makariantz 1 , Maria A. Karnaushkina 2 , Svetlana A. Salamaikina 3 , Konstantin O. Mironov 3 , Sergey L. Babak 4 , Anastasia D. Strutynskaya 2

1 Central Research Institute of Tuberculosis, Moscow, Russia; Patrice Lumumba Peoples' Friendship University of Russia, Moscow, Russia;

2 Patrice Lumumba Peoples' Friendship University of Russia, Moscow, Russia;

3 Central Research Institute of Epidemiology, Moscow, Russia;

4 Yevdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia

References

1. Зимина В.Н., Дегтярева С.Ю., Белобородова Е.Н. и др. Микобактериозы: современное состояние проблемы. Клиническая микробиология и антимикробная химиотерапия. 2017;19(4):276-82. Zimina V.N., Degtjareva S.Ju., Beloborodova E.N. et al. Mycobacterioses: current state of the problem. Clinical microbiology and antimicrobial chemotherapy. 2017;19(4):276-82 (in Russian).
2. Макарова М.В., Гунтупова Л.Д. Нетуберкулезные микобактерии. БИОпрепараты. Профилактика, диагностика, лечение. 2020;20(2):97-102. Makarova M.V., Guntupova L.D. Non-tuberculous mycobacteria. BIOpreparations. Prevention, diagnosis, treatment. 2020;20(2):97-102 (in Russian).
3. Лямин А.В., Ковалев А.М., Жестков А.В. и др. Нетуберкулезные микобактерии: современные возможности видовой идентификации. Клиническая микробиология и антибактериальная химиотерапия. 2017;19(1):11-4. Ljamin A.V., Kovaljov A.M., Zhestkov A.V., et al. Non-tuberculous mycobacteria: modern possibilities of species identification. Clinical microbiology and antibacterial chemotherapy. 2017;19(1):11-14. (in Russian).
4. Brode SK, Marchand-Austin A, Jamieson FB, Marras TK. Nontuberculous Mycobacteria, Ontario, Canada. Emerg Infect Dis 2017;23(11):1898-901. DOI: 10.3201/eid2311.170959
5. Park SC, Kang MJ, Han CH et al. Prevalence, incidence, and mortality of nontuberculous mycobacterial infection in Korea: a nationwide population-based study. BMC Pulm Med 2019;19(1):140. DOI: 10.1186/s12890-019-0901-z
6. Donohue MJ, Wymer L. Increasing Prevalence Rate of Nontuberculous Mycobacteria Infections in Five States, 2008–2013. Annals ATS 2016;13(12):2143-50. DOI: 10.1513/AnnalsATS.201605-353OC
7. Chin KL, Sarmiento ME, Alvarez-Cabrera N et al. Pulmonary non-tuberculous mycobacterial infections: current state and future. Eur J Clin Microbiol Infect Dis 2020;39(5):799-826. DOI: 10.1007/s10096-019- 03771-0
8. Henkle E, Winthrop KL. Nontuberculous mycobacteria infections in immunosuppressed hosts. Clin Chest Med 2015;36:91-9. DOI: 10.1016/j.ccm.2014.11.002
9. Koh WJ, Kwon OJ, Kim EJ et al. NRAMP1 Gene Polymorphism and Susceptibility to Nontuberculous Mycobacterial Lung Diseases. Chest 2005;128(1):94-101. DOI: 10.1378/chest.128.1.94
10. Wu MF, Shu CC, Wang JY et al. NLRP3 inflammasome is attenuated in patients with Mycobacterium avium complex lung disease and correlated with decreased interleukin-1β response and host susceptibility. Sci Rep 2019;9(1):12534. DOI: 10.1038/s41598-019-47609-3
11. Yim JJ, Kim HJ, Kwon OJ, Koh WJ. Association between microsatellite polymorphisms in intron II of the human Toll-like receptor 2 gene and nontuberculous mycobacterial lung disease in a Korean population. Human Immunology 2008;69(9):572-6. DOI: 10.1016/j.humimm.2008.06.003
12. Cho J, Park K, Choi SM et al. Genome-wide association study of non-tuberculous mycobacterial pulmonary disease. Thorax 2021;76(2):169-77. DOI: 10.1136/thoraxjnl-2019-214430
13. Pan SW, Feng JY, Wu LS et al. Sex-Specific Associations Between Susceptibility to Mycobacterium avium Complex Lung Disease and Programmed Cell Death 1 Gene Polymorphisms. J Infect Dis 2023;228(1):18-27. DOI: 10.1093/infdis/jiac396
14. Ratnatunga CN, Lutzky VP, Kupz A et al. The rise of non-tuberculosis mycobacterial lung disease. Front Immunol 2020;11:303. DOI: 10.3389/fimmu.2020.00303
15. Daley CL, Iaccarino JM, Lange C et al. Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline. Clin Infect Dis 2020;71(4):e1-e36. DOI: 10.1093/cid/ciaa241

For citation:Makariantz N.N., Karnaushkina M.A., Salamaikina S.A., Mironov K.O., Babak S.L., Strutynskaya A.D. Clinical case of progressive pulmonary mycobacteriosis with potential genetic predisposition in a patient with mild bronchial asthma. Clinical analysis in general medicine. 2024; 5 (2): 72–77 (In Russ.). DOI: 10.47407/kr2023.5.2.00391


All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

  • About
  • Editorial board
  • Ethics
  • For authors
  • Author fees
  • Peer review
  • Contacts

oa
crossref
анри


  Indexing

doaj
elibrary

Address of the Editorial Office:

127055, Moscow, s/m 37

Correspondence address:

115054, Moscow, Zhukov passage, 19, fl. 2, room XI


Managing Editor:

+7 (495) 926-29-83

id@con-med.ru